These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 22983659
1. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis. Arai S, Kurasawa K, Maezawa R, Owada T, Okada H, Fukuda T. Mod Rheumatol; 2013 Sep; 23(5):872-83. PubMed ID: 22983659 [Abstract] [Full Text] [Related]
2. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis]. Chen F, Shu XM, Wang DX, Xie Y, Wang GC. Zhonghua Yi Xue Za Zhi; 2012 Aug 21; 92(31):2182-5. PubMed ID: 23158422 [Abstract] [Full Text] [Related]
3. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study. Chen F, Lu X, Shu X, Peng Q, Tian X, Wang G. Intern Med J; 2015 Jun 21; 45(6):641-7. PubMed ID: 25827843 [Abstract] [Full Text] [Related]
5. KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker. Hanaoka M, Katsumata Y, Kawasumi H, Kawaguchi Y, Yamanaka H. Mod Rheumatol; 2019 Jul 21; 29(4):625-632. PubMed ID: 30484723 [Abstract] [Full Text] [Related]
12. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N, Fujimoto M, Tamaki K. Rheumatology (Oxford); 2002 Nov 21; 41(11):1268-72. PubMed ID: 12421999 [Abstract] [Full Text] [Related]
13. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. Fathi M, Barbasso Helmers S, Lundberg IE. J Intern Med; 2012 Jun 21; 271(6):589-97. PubMed ID: 21950266 [Abstract] [Full Text] [Related]
14. Prognostic performance of Krebs von den Lungen-6, surfactant protein A, surfactant protein D levels in the serum and bronchoalveolar lavage fluid in chronic fibrosing interstitial pneumonia: a retrospective study. Wakamatsu K, Nagata N, Kumazoe H, Hara M, Asai S, Noda N, Kiyotani R, Fukui I, Tatsuta M, Katahira K, Akasaki T, Maki S, Miyamoto K, Otsuka J, Izumi M, Kawasaki M, Yamada H. BMC Pulm Med; 2024 Aug 22; 24(1):404. PubMed ID: 39174992 [Abstract] [Full Text] [Related]
15. Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia. Fukuhara N, Tanino Y, Sato S, Fukuhara A, Uematsu M, Nikaido T, Misa K, Sato Y, Saito J, Wang X, Munakata M. Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep 14; 32(3):265-70. PubMed ID: 26422573 [Abstract] [Full Text] [Related]
20. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, Kamatani N, Kashiwazaki S. J Rheumatol; 2000 May 14; 27(5):1164-70. PubMed ID: 10813282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]